Skip to main content
logo
Ascendis Pharma A/S (FRA:A71)
Germany flag Germany · Delayed Price · Currency is EUR
196.00
0.00 (0.00%)
At close: Apr 2, 2026

Ascendis Pharma Revenue

In the year 2025, Ascendis Pharma had annual revenue of 720.13M EUR with 98.03% growth. Ascendis Pharma had revenue of 247.50M in the quarter ending December 31, 2025, with 42.31% growth.

Revenue
720.13M
Revenue Growth
+98.03%
P/S Ratio
16.93
Revenue / Employee
605.66K
Employees
1,189
Market Cap
12.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025720.13M356.49M98.03%
Dec 31, 2024363.64M96.92M36.34%
Dec 31, 2023266.72M215.54M421.20%
Jan 1, 202351.17M43.40M557.93%
Dec 31, 20217.78M825.00K11.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biotest Aktiengesellschaft635.20M
2invest AG28.07M
Darwin AG27.35M
Paion AG14.81M
co.don AG6.24M
MagForce AG1.08M
Biomark Diagnostics57.01K
bioXXmed AG20.49K
Revenue Rankings

Ascendis Pharma News

More News